ISSN : 2146-3123
E-ISSN : 2146-3131

Slider 2
Slider 1
Slider 3
Slider 4
Slider 5
Slider 6
Slider 7

News See All

The question “Can today’s medical education content really respond to the pandemic(s)?” is open for discussion. Community-based medical education is the delivery of medical education in a specific social context.
We are living in rare and unprecedented times. As the coronavirus disease 2019 (COVID-19) pandemic interrupted many things in the world, it also disrupted medical education.
There is a lack of data regarding the effects of “Coronavirus disease-2019” on pediatric patients with rheumatic diseases. Additionally, there are three controversial circumstances that patients with rheumatic diseases are believed... "Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon"
The COVID-19 outbreak has led to a speedy publication of many academic articles about the new coronavirus. Scientists and editors are under immense pressure to share their findings... "Editor Responsibility and Scientific Integrity During the COVID-19 Outbreak"  
A 25-year-old woman who was 35 weeks and 1 day pregnant was admitted to a local hospital on February 9, 2020, presenting with a history of fatigue and mild dry cough for 3 days.  
Since December 2019, the outbreak of the novel coronavirus has impacted nearly >90,000 people in more than 75 countries. In this case report, we aim to define the chest computed tomography findings of 2019-novel coronavirus associated with pneumonia and its successful resolution after treatment. "CT Manifestations of Novel Coronavirus Pneumonia: A Case Report by An P,  et al."

Articles See All

Zafer Koçak
According to the 2020 Journal Citation Report by Clarivate Analytics, the impact factor of Balkan Medical Journal arose by 1.53 in 2019, which reflects 27% increase compared to last year. The upward trend in the journal's impact factor stemmed from…
Saurav Das, Kevin Denny John, Satheesh Kumar Bokka, et al.
In this invited review, the authors highlight the key concepts related to the patho-physiology of large vessel occlusion strokes, current evidence on post-recanalization blood pressure management, and to provide recommendations…
Esin Gezmiş, Charles Peebles, Andrew Flett, et al.
In this cross-sectional study on cardiac magnetic resonance, the purpose is to compare modified look-locker inversion recovery and shortened modified look-locker inversion recovery sequences in terms of T1 reactivity and to determine the relationship between…
Shuangjian Jiang, Yun Yang, Rongpei Wu, et al.
In this case-series study on juxtaglomerular cell tumor, authors report the clinical and pathological characteristics of 9 cases, as well as the treatment methods and outcomes.
Sinem Yalçıntepe, Hakan Gürkan, Engin Atlı, et al.
To date, approximately 1000 mutations have been reported in clinically and genetically heterogeneous cystic fibrosis. In this letter, the authors present two cases of cystic fibrosis with compound heterozygous CFTR variants identified for the first time.

Image Corner

A 54-year-old male patient was admitted with a 3-day history of fever. Physical examination revealed bilateral edema in the lower extremities. Laboratory studies did not reveal any abnormalities, including serum immunoglobulins and monoclonal protein. Computed tomography showed mild splenomegaly and 18F-FDG-PET/CT revealed pleural effusion and systemic mild lymphadenopathy.

News from Balkan Medical Journal See All

The effort to maintain the editorial freedom has posed distinct challenges arising from regional dynamics in the Balkan region, as in any part of the world. For a journal to be successful in the international arena, reasonably organized managerial processes are required. Clear definitions of work packages, workflows, duties and responsibilities, and assignment and dismissal criteria are essential for the transparency of managerial processes. The journal’s owner, editor-in-chief, editorial board, publisher, and authors effectively communicating with each other within the framework of rules will prevent chaotic and destructive conflicts that may harm the reputation and its mission. The attempt to establish a legal regulation, an agreement between the owner and the editor, and an ombudsman began approximately five years ago for Balkan Medical Journal. Throughout this process, the journal’s management has endeavored to consult the opinions of the journal’s owner and the university legal regulation committee to establish a legal regulation for the journal that is ethical, practical, sustainable, and conforms to the national laws and international scientific values. We believe the journal legal regulation, finalized in January 2019 and presented below, serves as a role model for all scientific circles and the Balkans and will contribute to the advancement of institutional scientific publications of medicine in the region. The journal’s editorial board extends its gratitude to all current and past employees, the Dean’s of the Faculty of Medicine of Trakya University, and to the current rectorate of Trakya University for their valuable contributions and encouragement to building the development of the journal legal regulation to protect editorial freedom and provide successful journal management of all Trakya University scientific journals.  
Balkan Medical Journal follows ICMJE recommendations. The ICMJE require authors to submit a data-sharing statement for randomized clinical trials. Authors must provide a data-sharing notification to indicate whether data will be shared. According to ICMJE “Data sharing statements must indicate the following: whether individual deidentified participant data (including data dictionaries) will be shared; what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism)” (for details: Balkan Medical Journal require authors to submit a data-sharing statement and register a data-sharing plan when registering a clinical trial on or after Jan 1, 2019.